abstract |
The present invention relates to pharmaceutical preparations, in particular to novel pharmaceutical preparations, wherein the active ingredient comprises human antibodies to human interleukin I beta (IL-1?), In particular ACZ885 antibodies, which pharmaceutical preparations are stable in storage and delivery, none. |